Online Spaced Education to Improve Fall Prevention by Patients With Multiple Sclerosis
- Conditions
- Education of Patients
- Interventions
- Other: Brochure EducationOther: Online Spaced Education
- Registration Number
- NCT03737097
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Brief Summary
Multiple sclerosis (MS) is a chronic, progressive and neurodegenerative inflammatory disease that affects young adults. In many countries it has been described as the main cause of neurological incapacity in this age group. Due to the neurological impairment, patients with multiple sclerosis have a high incidence of fall. According to studies, MS patients fall three times more than general population. In the present study, the question to be answered is: education of individuals with MS on fall prevention using the method of online spaced education provides better retention of knowledge than the traditional method? This is a clinical trial to compare two methods of education of MS patients for prevention of fall. First stage: Development and validation of materials. Step two: Pilot questions with MS patients. Step three: Intervention and evaluation of outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 320
- Multiple sclerosis diagnosis
- Accept to be part in the study
- Have valid e-mail address
- Healthcare professionals;
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Brochure Education Brochure Education The control cohort will receive the fall prevention education in bolus through a Brochure developed by the National Multiple Sclerosis Society. The brochure was translated to portuguese and will be used in the study with authorization of the Society. Online Spaced Education Online Spaced Education The intervention cohort will participate in an online spaced education on fall prevention education developed for patients with multiple sclerosis.
- Primary Outcome Measures
Name Time Method Change in test scores between cohorts measured in weeks 1-24 Months 1-6 Test scores on fall prevention strategies tests in both cohorts will be registered and compared in weeks 1, 12 and 24
- Secondary Outcome Measures
Name Time Method Fall rate Months 1-6 Number of self-reported falls registered by the patients in both cohorts will be compared in weeks 1, 12 and 24
Adherence to fall prevention strategies Months 1-6 The study will apply the Falls Prevention Strategies Survey in both cohorts in weeks 1, 12 and 24. It is a self-report instrument addressing protective behaviors related to fall risk among adults with multiple sclerosis (MS) (eg, monitoring MS symptoms, wearing proper footwear, modifying activities). Response options reflect the frequency with which the respondent engages in the behavior (ie, never, sometimes, regularly)
Individuals satisfaction with the fall prevention education method Months 3-6 Individuals will be asked to evaluate their satisfaction with the method they were signed in the study by a five-point Likert scale (very dissatisfied, dissatisfied, neutral, satisfied, very satisfied). Answers will be compared between both cohorts in weeks 12 and 24.
Baseline knowledge levels of patients assessed via their initial responses to the questions Month 1 Previous knowledge about fall prevention strategies will be evaluated in week 1 in both cohorts and compared
Pre and post-test performances differences by history of falls Months 1-6 Patient performance in pre and post-tests will be evaluated in both cohorts and will be compared between fallers and non-fallers in the group and between the cohorts in weeks 1, 12 and 24. We will consider fallers the individuals, in both groups, that have at least one reported fall in the past six months in the enrollment in the study.
Pre and post-test performances differences by age Month 1-6 Patient performance will be evaluated in both cohorts and compared by age in weeks 1, 12 and 24
Pre and post-test performances differences by gender Month 1-6 Patient performance will be evaluated in both cohorts and compared by gender in weeks 1, 12 and 24
Trial Locations
- Locations (1)
Sociedade Benef Israelitabras Hospital Albert Einstein
🇧🇷São Paulo, Sao Paulo, Brazil